SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-22-303764
Filing Date
2022-12-13
Accepted
2022-12-13 16:02:15
Documents
12
Period of Report
2022-12-13
Items
Item 5.07: Submission of Matters to a Vote of Security Holders

Document Format Files

Seq Description Document Type Size
1 8-K d424423d8k.htm   iXBRL 8-K 47608
  Complete submission text file 0001193125-22-303764.txt   173083

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA ymtx-20221213.xsd EX-101.SCH 2842
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE ymtx-20221213_lab.xml EX-101.LAB 17995
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE ymtx-20221213_pre.xml EX-101.PRE 11256
6 EXTRACTED XBRL INSTANCE DOCUMENT d424423d8k_htm.xml XML 3398
Mailing Address 40 GUEST STREET SUITE 4410 BOSTON MA 02135
Business Address 40 GUEST STREET SUITE 4410 BOSTON MA 02135 617-409-5300
YUMANITY THERAPEUTICS, INC. (Filer) CIK: 0001445283 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37695 | Film No.: 221459698
SIC: 2834 Pharmaceutical Preparations